InMed Pharmaceuticals Inc. stock is up 14.17% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30% of the previous 10 March’s closed higher than February.
InMed Pharmaceuticals Inc. researches and develops cannabinoid-based therapies. Lead product INM-755, a cannabinoidol topical cream, is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing InM-088, which is in preclinical studies for the. treatment of glaucoma and pain.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!